More of a little curiosity or some funny pastime while we are waiting for official newsflow reg enrollment or partnering. But it seems as if AI is on our side! ;-)
„Medical trials are as expensive and time consuming as they are vital. But AI has emerged that might well be able to predict results.
Given that, a positive trial result can put a rocket up a biotech company’s share price, while a negative one can send it into a tailspin.
The wonders of artificial intelligence mean that it is possible to predict a trial result with 90 per cent accuracy, according to life-sciences nanocap Opyl.
Opthea (ASX:OPT) has two Phase 3 trials for the eye condition wet aged-related macular degeneration, due to report mid next year. Combining the company’s therapy with different “standard of care” drugs, the trials are rated a solid 63.8 per cent and 52.32 per cent chance of success.“
=> click here <=
To be taken with a grain of smile…
- Forums
- ASX - By Stock
- Hang in there!!
More of a little curiosity or some funny pastime while we are...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
|
|||||
Last
36.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $398.3M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 58601 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 0.370 |
1 | 287 | 0.365 |
4 | 78252 | 0.360 |
5 | 252553 | 0.355 |
11 | 360315 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 58601 | 2 |
0.380 | 66000 | 3 |
0.385 | 96007 | 2 |
0.390 | 7694 | 2 |
0.395 | 5000 | 1 |
Last trade - 09.30am 11/07/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online